Gallus is capitalizing on the extraordinary flexibility afforded by both single-use and flexible stainless steel technologies along with the extensive manufacturing experience of Gallus's team, to provide innovative solutions for established as well as development-stage biopharmaceutical companies.
Gallus’ facility in Princeton, New Jersey has over 50,000 square feet of lab space for process development, cGMP clinical and small-scale commercial manufacturing of mammalian cell culture-based biopharmaceuticals. The process development laboratories in Princeton are used for development of IgG monoclonal antibody products as well as complex protein products such as IgMs, fusion proteins, enzymes and collagens. The pilot facility is used for pilot runs, engineering runs and for the production of non-GMP materials. The cGMP manufacturing facility in Princeton is used for the manufacture of clinical-stage biopharmaceutical products and has been used for the manufacture of a commercial monoclonal antibody product for more than 17 years. Aseptic filling, services, vial inspection and labeling are performed in our recently renovated aseptic filling suite.
Gallus’ facility in St. Louis has over 30,000 square feet of lab space for process development and cGMP clinical and commercial manufacturing of mammalian cell culture-based biopharmaceuticals. All of our manufacturing suites are designed with a high degree of flexibility to meet clients’ needs with optimum efficiency. From modular capacity that can be custom built to clients’ specification, to options on the latest single-use or flexible stainless steel technology, and a selection of business models that bring varying advantages, Gallus has one of the most flexible contract manufacturing offerings. We’re one of very few CMOs with a strong track record of mammalian cell culture and protein purification in batch, fed batch and perfusion modes. And we’re a pure-play CMO, ensuring all of our focus and efforts are on our clients’ projects.